Question
a. Merck INCOME STATEMENT Year 3 Estimate Year 2 Year 1 Net sales 47,716 40,343 Cost of goods 28,977 22,444 Gross profit 18,739 17,900 Selling
a.
Merck | |||
INCOME STATEMENT | Year 3 Estimate | Year 2 | Year 1 |
Net sales | 47,716 | 40,343 | |
Cost of goods | 28,977 | 22,444 | |
Gross profit | 18,739 | 17,900 | |
Selling general & administrative expense | 6,531 | 6,469 | |
Depreciation & amortization expense | 1,464 | 1,277 | |
Interest expense | 342 | 329 | |
Income before tax | 10,403 | 9,824 | |
Income tax expense | 3,121 | 3,002 | |
Net income | 7,282 | 6,822 | |
Outstanding shares | 2,976 | 2,976 | 2,968 |
RATIOS | |||
Sales growth | 18.27% | 18.27% | |
Gross Profit Margin | 39.27% | 39.27% | |
Selling General & Administrative Exp / Sales | 13.69% | 13.69% | |
DEPRECIATION (depn exp / pr yr PPE gross) | 8.76% | 8.76% | |
INT (int / pr yr LTD) | 4.94% | 4.94% | |
Tax (Inc Tax / Pre-tax inc) | 30.00% | 30.00% | |
BALANCE SHEET | Year 3 Estimate | Year 2 | Year 1 |
Cash | 3,287 | 4,255 | |
Receivables | 5,215 | 5,262 | |
Inventories | 3,579 | 3,022 | |
Other | 880 | 1,059 | |
Total current assets | 12,961 | 13,598 | |
Property, plant & equipment | 18,956 | 16,707 | |
Accumulated depreciation | 5,853 | 5,225 | |
Net property & equipment | 13,103 | 11,482 | |
Other assets | 17,942 | 15,075 | |
Total assets | 44,007 | 40,155 | |
Accounts payable & accrued liabilities | 5,904 | 5,391 | |
Short-term debt & cmltd | 4,067 | 3,319 | |
Income taxes | 1,573 | 1,244 | |
Total current liab | 11,544 | 9,954 | |
Deferred income, taxes and other | 11,614 | 11,768 | |
Long term debt | 4,799 | 3,601 | |
Total liabilities | 27,957 | 25,323 | |
Common stock | 30 | 30 | |
Capital surplus | 6,907 | 6,266 | |
Retained earnings | 31,500 | 27,395 | |
OTHER EQUITIES | 0 | 0 | |
Treasury stock | 22,387 | 18,858 | |
Shareholder equity | 16,050 | 14,832 | |
Total liabilities & net worth | 44,007 | 40,155 | |
RATIOS | |||
AR turn | 9.15 | 9.15 | 7.67 |
INV turn | 8.10 | 8.10 | 7.43 |
AP turn | 4.91 | 4.91 | 4.16 |
Tax Pay (Tax pay / tax exp) | 50.41% | 50.41% | 41.45% |
FLEV (Assets/Equity) | 2.35 | 2.74 | 2.71 |
Div/sh | $1.06 | $1.06 | $0.98 |
CAPEX | 5,100 | 4312 | 3641 |
CAPEX/Sales | 9.04% | 9.04% | 9.03% |
Additional Balance Sheet Assumptions:
Other Current Assets- Unchanged
Other Assets- Unchanged
Deferred Income Taxes & Other- Unchanged
Short Term Debt & CMLTD- Unchanged
Long Term Debt- Unchanged
Required:
1)Prepare the estimated Year 3 projected income statement using the ratios provided.
2)Prepare the estimated Year 3 projected balance sheet using the ratios and assumptions provided. Remember that cash is your residual account to make the balance sheet, balance.
3)Assuming that Merck requires an ending 6.5% cash balance for sales projected in Year 3, does it have a surplus or a deficit of cash relative to the requirement. By how much? If a deficit, suggest how the deficit might be financed. If a surplus, suggest how it might be used.
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started